Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents

Phillip A. Sharp

Massachusetts Institute of Technology · Biology

Active 1968–2025

h-index227
Citations196.5k
Papers93427 last 5y
Funding$85.5M

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Phillip A. Sharp — sign in to PhdFit.Sign in

About

Phillip A. Sharp is an Institute Professor and Professor of Biology Emeritus at MIT, affiliated with the Koch Institute for Integrative Cancer Research. His research has focused on various aspects of gene expression in mammalian cells, including transcription, the roles of non-coding RNAs such as microRNAs, and RNA splicing. He has investigated small, non-coding RNAs called microRNAs (miRNAs), which regulate over half of the genes in mammalian cells at the stages of translation and mRNA stability. Additionally, his work explores the processes underlying transcription from the anti-sense strand, known as divergent transcription, as well as the relationship between transcription elongation, RNA splicing, and chromatin modifications. Throughout his career, Sharp has made significant contributions to understanding gene regulation mechanisms and has been recognized with numerous awards, including the Nobel Prize in Physiology or Medicine in 1993, the National Medal of Science in 2004, and the AACR Award for Lifetime Achievement in Cancer Research in 2020.

Research topics

  • Biology
  • Genetics
  • Computer Science
  • Biophysics
  • Internal medicine
  • Medicine
  • Physics
  • Cell biology
  • Computational biology

Selected publications

  • RNA-Mediated Feedback Control of Transcriptional Condensates

    Cell · 2020 · 614 citations

  • Partitioning of cancer therapeutics in nuclear condensates

    Science · 2020 · 517 citations

    The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was als…

  • RNA in formation and regulation of transcriptional condensates

    RNA · 2021-11-12 · 139 citations

    reviewOpen access1st author

    Macroscopic membraneless organelles containing RNA such as the nucleoli, germ granules, and the Cajal body have been known for decades. These biomolecular condensates are liquid-like bodies that can be formed by a phase transition. Recent evidence has revealed the presence of similar microscopic condensates associated with the transcription of genes. This brief article summarizes thoughts about the importance of condensates in the regulation of transcription and how RNA molecules, as components…

  • Single-cell nascent RNA sequencing unveils coordinated global transcription

    Nature · 2024-06-05 · 108 citations

    articleOpen accessSenior author

    Abstract Transcription is the primary regulatory step in gene expression. Divergent transcription initiation from promoters and enhancers produces stable RNAs from genes and unstable RNAs from enhancers 1,2 . Nascent RNA capture and sequencing assays simultaneously measure gene and enhancer activity in cell populations 3 . However, fundamental questions about the temporal regulation of transcription and enhancer–gene coordination remain unanswered, primarily because of the absence of a single-ce…

  • Oncogenic <i>CDK13</i> mutations impede nuclear RNA surveillance

    Science · 2023-04-20 · 53 citations

    articleOpen access

    RNA surveillance pathways detect and degrade defective transcripts to ensure RNA fidelity. We found that disrupted nuclear RNA surveillance is oncogenic. Cyclin-dependent kinase 13 ( CDK13 ) is mutated in melanoma, and patient-mutated CDK13 accelerates zebrafish melanoma. CDK13 mutation causes aberrant RNA stabilization. CDK13 is required for ZC3H14 phosphorylation, which is necessary and sufficient to promote nuclear RNA degradation. Mutant CDK13 fails to activate nuclear RNA surveillance, caus…

Recent grants

Frequent coauthors

  • C. Collard

    Institut Pluridisciplinaire Hubert Curien

    236 shared
  • J. Andreä

    Institut Pluridisciplinaire Hubert Curien

    235 shared
  • E. Conte

    Institut Pluridisciplinaire Hubert Curien

    234 shared
  • D. Blöch

    Institut Pluridisciplinaire Hubert Curien

    232 shared
  • E. C. Chabert

    Institut Pluridisciplinaire Hubert Curien

    221 shared
  • M. Lethuillier

    Institute of Nuclear Physics of Lyon

    212 shared
  • B. Ille

    Institute of Nuclear Physics of Lyon

    191 shared
  • P. Verdier

    Institute of High Energy Physics

    190 shared

Labs

  • Phillip A. Sharp LabPI

Awards & honors

  • AACR Award for Lifetime Achievement in Cancer Research (2020…
  • AACR Distinguished Award for Extraordinary Scientific Innova…
  • Royal Society of London, Foreign Fellow (2011)
  • National Science Foundation, National Medal of Science (2004…
  • The Nobel Foundation, Nobel Prize in Physiology or Medicine…

Similar researchers at Massachusetts Institute of Technology

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Phillip A. Sharp

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup